Denintuzumab
Product Specifications
CAS Number
1630074-14-4
Target
ADC Antibody|||Immunology/Inflammation related
Related Pathways
Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related
Purity
1
Bioactivity
Denintuzumab (hBU 12) is a humanized monoclonal antibody targeting CD19, used in the synthesis of ADC compound Denintuzumab Mafodotin and in the study of acute lymphoblastic leukemia.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2128310-01 0.1 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details 
MBS2128310-02 0.2 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details 
MBS2128310-03 0.5 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details MBS2128310-04 1 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details MBS2128310-05 5 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details MBS2128310-06 5x 5 mL
PE Linked Monoclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
Ask
View Details